Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 104

1.

Eye drop technique and patient-reported problems in a real-world population of eye drop users.

Mehuys E, Delaey C, Christiaens T, Van Bortel L, Van Tongelen I, Remon JP, Boussery K.

Eye (Lond). 2019 Nov 5. doi: 10.1038/s41433-019-0665-y. [Epub ahead of print]

PMID:
31690823
2.

The perspectives of parents, general practitioners, and community pharmacists about treating an ill child in primary care: a comparative study.

Verhelst S, De Bruyne P, Van Winckel M, Boussery K, Tommelein E.

Eur J Pediatr. 2019 Oct 29. doi: 10.1007/s00431-019-03476-8. [Epub ahead of print]

PMID:
31659469
3.

Pharmaceutical compounding of orphan active ingredients in Belgium: how community and hospital pharmacists can address the needs of patients with rare diseases.

Vanhoorne V, Peeters E, Van Tongelen I, Boussery K, Wynendaele E, De Spiegeleer B, Remon JP, Vervaet C.

Orphanet J Rare Dis. 2019 Aug 1;14(1):186. doi: 10.1186/s13023-019-1154-x.

4.

Pharmacist-led medication review in community-dwelling older patients using the GheOP3 S-tool: General practitioners' acceptance and implementation of pharmacists' recommendations.

Foubert K, Mehuys E, Maesschalck J, De Wulf I, Wuyts J, Foulon V, Lelubre M, De Vriese C, Somers A, Petrovic M, Boussery K.

J Eval Clin Pract. 2019 Jul 22. doi: 10.1111/jep.13241. [Epub ahead of print]

PMID:
31332905
5.

Application of the GheOP3S-tool in nursing home residents: acceptance and implementation of pharmacist recommendations.

Foubert K, Muylaert P, Mehuys E, Somers A, Petrovic M, Boussery K.

Acta Clin Belg. 2019 Jun 26:1-9. doi: 10.1080/17843286.2019.1634323. [Epub ahead of print]

PMID:
31241000
6.

Detection of potentially inappropriate prescribing in older patients with the GheOP³S-tool: completeness and clinical relevance.

Kympers C, Tommelein E, Van Leeuwen E, Boussery K, Petrovic M, Somers A.

Acta Clin Belg. 2019 Apr;74(2):126-136. doi: 10.1080/17843286.2019.1568353. Epub 2019 Jan 30.

PMID:
30698077
7.

Switchability of Gabapentin Formulations: A Randomized Trial to Assess Bioequivalence Between Neurontin and Gabasandoz on the Individual Subject Level.

Van Lancker G, Van Bortel L, Delafontaine B, Boussery K, Swart E, Chahbouni A, Van Bocxlaer J, Colin P.

Clin Pharmacol Ther. 2019 Jul;106(1):195-203. doi: 10.1002/cpt.1353. Epub 2019 Mar 2.

PMID:
30636281
8.

Pharmacokinetic evaluation of linezolid administered intravenously in obese patients with pneumonia.

Xie F, Mantzarlis K, Malliotakis P, Koulouras V, Degroote S, Koulenti D, Blot S, Boussery K, Van Bocxlaer J, Colin P; LIMOP study collaborators .

J Antimicrob Chemother. 2019 Mar 1;74(3):667-674. doi: 10.1093/jac/dky500.

PMID:
30535122
9.

Self-Medication With Over-the-Counter Analgesics: A Survey of Patient Characteristics and Concerns About Pain Medication.

Mehuys E, Crombez G, Paemeleire K, Adriaens E, Van Hees T, Demarche S, Christiaens T, Van Bortel L, Van Tongelen I, Remon JP, Boussery K.

J Pain. 2019 Feb;20(2):215-223. doi: 10.1016/j.jpain.2018.09.003. Epub 2018 Sep 28.

PMID:
30273688
10.

Implementation study of an intermediate medication review in Belgian community pharmacies.

Lelubre M, Wuyts J, Maesschalck J, Duquet N, Foubert K, Hutsebaut C, Moullin J, De Wulf I, Boussery K, Foulon V, De Vriese C.

Res Social Adm Pharm. 2019 Jun;15(6):710-723. doi: 10.1016/j.sapharm.2018.09.002. Epub 2018 Sep 12.

11.

A shared medication scheme for community dwelling older patients with polypharmacy receiving home health care: role of the community pharmacist.

Foubert K, Mehuys E, Claes L, Van Den Abeele D, Haems M, Somers A, Petrovic M, Boussery K.

Acta Clin Belg. 2019 Oct;74(5):326-333. doi: 10.1080/17843286.2018.1521903. Epub 2018 Sep 20.

PMID:
30235081
12.

Studying the impact of a medication use evaluation for polymedicated older patients by the community pharmacist (SIMENON): study protocol.

Wuyts J, Maesschalck J, De Wulf I, Foubert K, Boussery K, De Lepeleire J, Foulon V.

BMC Health Serv Res. 2018 Aug 8;18(1):623. doi: 10.1186/s12913-018-3440-z.

13.

An Evidence-Based Procedure for Self-Management of Medication in Hospital: Development and Validation of the SelfMED Procedure.

Vanwesemael T, Dilles T, Van Rompaey B, Boussery K.

Pharmacy (Basel). 2018 Jul 26;6(3). pii: E77. doi: 10.3390/pharmacy6030077.

14.

The willingness and attitude of patients towards self-administration of medication in hospital.

Vanwesemael T, Boussery K, van den Bemt P, Dilles T.

Ther Adv Drug Saf. 2018 Jun;9(6):309-321. doi: 10.1177/2042098618764536. Epub 2018 Mar 26.

15.

Development and Application of the GheOP3S-Tool Addendum on Potentially Inappropriate Prescribing (PIP) of Renally Excreted Active Drugs (READs) in Older Adults with Polypharmacy.

Wazzan AAA, Tommelein E, Foubert K, Bonassi S, Onder G, Somers A, Petrovic M, Boussery K.

Drugs Aging. 2018 Apr;35(4):343-364. doi: 10.1007/s40266-018-0530-x.

PMID:
29508369
16.

The Introduction of a Full Medication Review Process in a Local Hospital: Successes and Barriers of a Pilot Project in the Geriatric Ward.

De Bock L, Tommelein E, Baekelandt H, Maes W, Boussery K, Somers A.

Pharmacy (Basel). 2018 Feb 28;6(1). pii: E21. doi: 10.3390/pharmacy6010021.

17.

Self-management of medication during hospitalisation: Healthcare providers' and patients' perspectives.

Vanwesemael T, Boussery K, Manias E, Petrovic M, Fraeyman J, Dilles T.

J Clin Nurs. 2018 Feb;27(3-4):753-768. doi: 10.1111/jocn.14084. Epub 2017 Nov 20.

PMID:
28960641
18.

SelfMED: Self-Administration of Medication in Hospital: A Prevalence Study in Flanders, Belgium.

Vanwesemael T, Van Rompaey B, Petrovic M, Boussery K, Dilles T.

J Nurs Scholarsh. 2017 May;49(3):277-285. doi: 10.1111/jnu.12290. Epub 2017 Apr 4.

PMID:
28376562
19.

[Medication screening by the community pharmacist in Belgium].

Tommelein E, Mehuys E, Van Tongelen I, Petrovic M, Somers A, Kympers C, Van Hees T, Christiaens T, Demarche S, Colin P, Boussery KJ.

J Pharm Belg. 2016 Dec;(4):4-13. Review. French.

PMID:
30281243
20.

Community pharmacists' evaluation of potentially inappropriate prescribing in older community-dwelling patients with polypharmacy: observational research based on the GheOP³S tool.

Tommelein E, Mehuys E, Van Tongelen I, Petrovic M, Somers A, Colin P, Demarche S, Van Hees T, Christiaens T, Boussery K.

J Public Health (Oxf). 2017 Sep 1;39(3):583-592. doi: 10.1093/pubmed/fdw108.

PMID:
27698269
21.

[Frequency and nature of drug related problems with corticosteroids in Belgian community pharmacies].

Lelubre M, Koubaity M, De Wulf I, Boussery K, De Meyer GRY, Foulon V, Lacour V, Steurbaut S, Van Hees T, Amighi K, Bugnon O, De Vriese C.

J Pharm Belg. 2016 Sep;(3):32-41. French.

PMID:
30281242
22.

[Reliability of OTC advertisement Relevance and quality of cited literature].

Claes L, De Vylder V, De Stercke L, Muyshondt I, Schotte S, Van Hooimissen A, Van Paemel N, Mehuys E, Boussery KJ.

J Pharm Belg. 2016 Sep;(3):14-20. French.

PMID:
30281240
23.

Potentially inappropriate prescribing in nursing home residents detected with the community pharmacist specific GheOP(3)S-tool.

Tommelein E, Mehuys E, Petrovic M, Somers A, Van Damme C, Pattyn E, Mattelin K, Boussery K.

Int J Clin Pharm. 2016 Oct;38(5):1063-8. doi: 10.1007/s11096-016-0366-6. Epub 2016 Aug 8.

PMID:
27503282
24.

Are antihistamines effective in children? A review of the evidence.

De Bruyne P, Christiaens T, Boussery K, Mehuys E, Van Winckel M.

Arch Dis Child. 2017 Jan;102(1):56-60. doi: 10.1136/archdischild-2015-310416. Epub 2016 Jun 22. Review.

PMID:
27335428
25.

Strategies for Determining Correct Cytochrome P450 Contributions in Hepatic Clearance Predictions: In Vitro-In Vivo Extrapolation as Modelling Approach and Tramadol as Proof-of Concept Compound.

T'jollyn H, Snoeys J, Van Bocxlaer J, De Bock L, Annaert P, Van Peer A, Allegaert K, Mannens G, Vermeulen A, Boussery K.

Eur J Drug Metab Pharmacokinet. 2017 Jun;42(3):537-543. doi: 10.1007/s13318-016-0355-0.

PMID:
27317395
26.

PK/PD Modelling of the QT Interval: a Step Towards Defining the Translational Relationship Between In Vitro, Awake Beagle Dogs, and Humans.

Marostica E, Van Ammel K, Teisman A, Gallacher D, Van Bocxlaer J, De Ridder F, Boussery K, Vermeulen A.

AAPS J. 2016 Jul;18(4):1000-12. doi: 10.1208/s12248-016-9920-3. Epub 2016 Apr 26.

PMID:
27116025
27.

Effects of Food and Pharmaceutical Formulation on Desmopressin Pharmacokinetics in Children.

Michelet R, Dossche L, De Bruyne P, Colin P, Boussery K, Vande Walle J, Van Bocxlaer J, Vermeulen A.

Clin Pharmacokinet. 2016 Sep;55(9):1159-70. doi: 10.1007/s40262-016-0393-4.

PMID:
27106176
28.

Analysis of drug use in institutionalized individuals with intellectual disability and tube feeding.

Joos E, Mehuys E, Remon JP, Van Winckel M, Boussery K.

Acta Clin Belg. 2016 Apr;71(2):76-80. doi: 10.1080/17843286.2015.1122332. Epub 2016 Feb 6.

PMID:
27075803
29.

Evaluating the implementation fidelity of New Medicines Service for asthma patients in community pharmacies in Belgium.

Fraeyman J, Foulon V, Mehuys E, Boussery K, Saevels J, De Vriese C, Dalleur O, Housiaux M, Steurbaut S, Naegels M, De Meyer GR, De Loof H, Van Hal G, Van den Broucke S.

Res Social Adm Pharm. 2017 Jan - Feb;13(1):98-108. doi: 10.1016/j.sapharm.2016.02.001. Epub 2016 Feb 12.

PMID:
26975932
30.

The heterogeneity of headache patients who self-medicate: a cluster analysis approach.

Mehuys E, Paemeleire K, Crombez G, Adriaens E, Van Hees T, Demarche S, Christiaens T, Van Bortel L, Van Tongelen I, Remon JP, Boussery K.

Pain. 2016 Jul;157(7):1464-71. doi: 10.1097/j.pain.0000000000000541.

PMID:
26967695
31.

Knowledge of staff members of residential care facilities for individuals with intellectual disability on medication administration via enteral feeding tube.

Joos E, Mehuys E, Van Bocxlaer J, Remon JP, Van Winckel M, Boussery K.

J Intellect Disabil Res. 2016 Nov;60(11):1066-1072. doi: 10.1111/jir.12263. Epub 2016 Mar 4.

PMID:
26939804
32.

Disulfiram inhibition of cyanide formation after acetonitrile poisoning.

De Paepe P, Colin P, Depuydt P, Decavele AS, De Smet J, Boussery K, Stove C, Benoit D, Verstraete A, Van Bocxlaer J, Buylaert W.

Clin Toxicol (Phila). 2016;54(1):56-60. doi: 10.3109/15563650.2015.1101770. Epub 2015 Dec 1.

PMID:
26623950
33.

[Drug shortages in the hospital: management, causes and budget impact].

Claus B, Pauwels K, Baert M, Depoorter J, De Weerdt E, Boussery K, De Spiegeleer B, Commeyne S.

J Pharm Belg. 2015 Mar;(1):24-34. French.

PMID:
26571794
34.

Medication administration via enteral feeding tube: a survey of pharmacists' knowledge.

Joos E, Verbeke S, Mehuys E, Van Bocxlaer J, Remon JP, Van Winckel M, Boussery K.

Int J Clin Pharm. 2016 Feb;38(1):10-5.

PMID:
26464336
35.

Drug administration via enteral feeding tube in residential care facilities for individuals with intellectual disability: A focus group study on guideline implementation.

Joos E, Van Tongelen I, Wijnants K, Mehuys E, Van Bocxlaer J, Remon JP, Grypdonck M, Van Winckel M, Boussery K.

J Intellect Disabil. 2016 Dec;20(4):329-340. Epub 2015 Oct 7.

PMID:
26446830
36.

Potentially inappropriate prescribing in community-dwelling older people across Europe: a systematic literature review.

Tommelein E, Mehuys E, Petrovic M, Somers A, Colin P, Boussery K.

Eur J Clin Pharmacol. 2015 Dec;71(12):1415-27. doi: 10.1007/s00228-015-1954-4. Epub 2015 Sep 26. Review.

PMID:
26407687
37.

Modelling of drug-induced QT-interval prolongation: estimation approaches and translational opportunities.

Marostica E, Van Ammel K, Teisman A, Boussery K, Van Bocxlaer J, De Ridder F, Gallacher D, Vermeulen A.

J Pharmacokinet Pharmacodyn. 2015 Dec;42(6):659-79. doi: 10.1007/s10928-015-9434-0. Epub 2015 Aug 11.

PMID:
26259721
38.

Physiologically Based Pharmacokinetic Predictions of Tramadol Exposure Throughout Pediatric Life: an Analysis of the Different Clearance Contributors with Emphasis on CYP2D6 Maturation.

T'jollyn H, Snoeys J, Vermeulen A, Michelet R, Cuyckens F, Mannens G, Van Peer A, Annaert P, Allegaert K, Van Bocxlaer J, Boussery K.

AAPS J. 2015 Nov;17(6):1376-87. doi: 10.1208/s12248-015-9803-z. Epub 2015 Jul 25.

39.

Older patients' prescriptions screening in the community pharmacy: development of the Ghent Older People's Prescriptions community Pharmacy Screening (GheOP³S) tool.

Tommelein E, Petrovic M, Somers A, Mehuys E, van der Cammen T, Boussery K.

J Public Health (Oxf). 2016 Jun;38(2):e158-70. doi: 10.1093/pubmed/fdv090. Epub 2015 Jul 13.

PMID:
26175537
40.

Age-related Differences in CYP3A Abundance and Activity in the Liver of the Göttingen Minipig.

Van Peer E, De Bock L, Boussery K, Van Bocxlaer J, Casteleyn C, Van Ginneken C, Van Cruchten S.

Basic Clin Pharmacol Toxicol. 2015 Nov;117(5):350-7. doi: 10.1111/bcpt.12410. Epub 2015 May 18.

41.

[Optimizing pharmacotherapy in patients with COPD by community-pharmacists: a cost-effectiveness analysis].

van Boven JF, Tommelein E, Boussery K, Mehuys E, Vegter S, Brusselle GG, Rutten-van Mölken MP, Postma MJ.

J Pharm Belg. 2014 Sep;(3):15-6. French. No abstract available.

PMID:
25226758
42.

[Effectiveness of pharmaceutical care for patients with COPD: translated review of the recently published PHARMACOP trial].

Tommelein E, Mehuys E, Van Hees T, Adriaens E, Van Bortel L, Christiaens T, Van Tongelen I, Remon JP, Boussery K, Brusselle G.

J Pharm Belg. 2014 Sep;(3):4-14. French.

PMID:
25226757
43.

Enzymatic tumour tissue digestion coupled to SPE-UPLC-Tandem Mass Spectrometry as a tool to explore paclitaxel tumour penetration.

Colin P, De Smet L, De Bock L, Goeteyn W, Boussery K, Vervaet C, Van Bocxlaer J.

Talanta. 2014 Nov;129:119-25. doi: 10.1016/j.talanta.2014.05.028. Epub 2014 May 24.

PMID:
25127573
44.

Characterisation of patient encounters in community pharmacies (with special focus on self-medication).

De Bolle L, Mehuys E, Christiaens T, Van Tongelen I, Remon JP, Boussery K.

Int J Pharm Pract. 2015 Jun;23(3):228-31. doi: 10.1111/ijpp.12138. Epub 2014 Aug 1.

PMID:
25082105
45.

Physiology-based IVIVE predictions of tramadol from in vitro metabolism data.

T'jollyn H, Snoeys J, Colin P, Van Bocxlaer J, Annaert P, Cuyckens F, Vermeulen A, Van Peer A, Allegaert K, Mannens G, Boussery K.

Pharm Res. 2015 Jan;32(1):260-74. doi: 10.1007/s11095-014-1460-x. Epub 2014 Jul 22.

PMID:
25048637
46.

Improving inhaler adherence in patients with chronic obstructive pulmonary disease: a cost-effectiveness analysis.

van Boven JF, Tommelein E, Boussery K, Mehuys E, Vegter S, Brusselle GG, Rutten-van Mölken MP, Postma MJ.

Respir Res. 2014 Jun 14;15:66. doi: 10.1186/1465-9921-15-66.

47.

Pharmaceutical care for patients with COPD in Belgium and views on protocol implementation.

Tommelein E, Tollenaere K, Mehuys E, Boussery K.

Int J Clin Pharm. 2014 Aug;36(4):697-701. doi: 10.1007/s11096-014-9956-3. Epub 2014 May 25.

PMID:
24858598
48.

A model based analysis of IPEC dosing of paclitaxel in rats.

Colin P, De Smet L, Vervaet C, Remon JP, Ceelen W, Van Bocxlaer J, Boussery K, Vermeulen A.

Pharm Res. 2014 Oct;31(10):2876-86. doi: 10.1007/s11095-014-1384-5. Epub 2014 May 22.

PMID:
24848338
49.

Self-medication in persistent rhinitis: overuse of decongestants in half of the patients.

Mehuys E, Gevaert P, Brusselle G, Van Hees T, Adriaens E, Christiaens T, Van Bortel L, Van Tongelen I, Remon JP, Boussery K.

J Allergy Clin Immunol Pract. 2014 May-Jun;2(3):313-9. doi: 10.1016/j.jaip.2014.01.009. Epub 2014 Mar 29.

PMID:
24811023
50.

[Drug related problems in Belgian community pharmacies].

Huysmans K, De Wulf I, Foulon V, De Loof H, Steurbaut S, Boussery K, De Vriese C, Lacour V, Van Hees T, De Meyer GR.

J Pharm Belg. 2014 Mar;(1):4-15. French.

PMID:
24804389

Supplemental Content

Loading ...
Support Center